Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02997657 · ClinicalTrials.gov registry record · NA
Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 271
- Enrollment target
NCT02997657: Completed NA study, sponsored by Brown University.
NCT02997657 is a NA study that has completed, run by Brown University. The registered enrollment target is 271 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02997657, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 271 participants
- Enrollment target
Study Summary
Positive Psychotherapy for Smoking Cessation (PPT-S) addresses an array of risk factors for poor smoking outcomes (low positive affect, depressive symptoms, and cynical cognitions), while also providing skills that may buffer against stress and negative affect. The overall objective of this project is to conduct a randomized controlled trial to test the efficacy of PPT-S, enhanced with text messaging, compared to a time-matched behavioral smoking cessation treatment. Participants in both treatment conditions will receive nicotine replacement therapy and a validated text-messaging intervention for smoking cessation that monitors progress in quitting smoking and extends smoking counseling outside of the individual face-to-face context.
Primary Outcome
Self-reported smoking abstinence biochemically confirmed with CO and cotinine
Interventions
- BEHAVIORAL Positive Psychotherapy
- BEHAVIORAL Standard smoking cessation counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 271 participants |
| Start Date | 2016-09 |
| Est. Completion | 2021-11-15 |
| Phase | NA |
What the finished NCT02997657 record still lists
NCT02997657 is an interventional study that assigns participants to a tested intervention. The registered 271 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Positive Psychotherapy is the first listed.
NCT02997657 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02997657 about?
NCT02997657 is a clinical study titled "Positive Psychotherapy for Smoking Cessation Enhanced With Text Messaging: A Randomized Controlled Trial". Positive Psychotherapy for Smoking Cessation (PPT-S) addresses an array of risk factors for poor smoking outcomes (low positive affect, depressive symptoms, and cynical cognitions), while also providing skills that may buffer against stress and negative affect. The overall objective of this project ...
What is the current status of trial NCT02997657?
This trial is currently completed. It is a NA study. The enrollment target is 271 participants. The study started on 2016-09. Estimated completion is 2021-11-15.
What interventions are being tested in trial NCT02997657?
The interventions under investigation include: Positive Psychotherapy (BEHAVIORAL), Standard smoking cessation counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02997657?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02997657's enrollment target sits among peer trials
271 387th of 2000 higher than 1,614 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03609216 · 271 participants · Phase 2
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations
- NCT02468024 · 272 participants · Phase 3
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
- NCT05519449 · 272 participants · Phase 1
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
- NCT06035939 · 272 participants · NA
SMYLS Multi-site Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia